Literature DB >> 16437061

Epilepsy: a review of selected clinical syndromes and advances in basic science.

Carl E Stafstrom1.   

Abstract

Epilepsy is a common neurologic disorder that manifests in diverse ways. There are numerous seizure types and numerous mechanisms by which the brain generates seizures. The two hallmarks of seizure generation are hyperexcitability of neurons and hypersynchrony of neural circuits. A large variety of mechanisms alters the balance between excitation and inhibition to predispose a local or widespread region of the brain to hyperexcitability and hypersynchrony. This review discusses five clinical syndromes that have seizures as a prominent manifestation. These five syndromes differ markedly in their etiologies and clinical features, and were selected for discussion because the seizures are generated at a different 'level' of neural dysfunction in each case: (1) mutation of a specific family of ion (potassium) channels in benign familial neonatal convulsions; (2) deficiency of the protein that transports glucose into the CNS in Glut-1 deficiency; (3) aberrantly formed local neural circuits in focal cortical dysplasia; (4) synaptic reorganization of limbic circuitry in temporal lobe epilepsy; and (5) abnormal thalamocortical circuit function in childhood absence epilepsy. Despite this diversity of clinical phenotype and mechanism, these syndromes are informative as to how pathophysiological processes converge to produce brain hyperexcitability and seizures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16437061     DOI: 10.1038/sj.jcbfm.9600265

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  Antiepileptic drugs induce subcritical dynamics in human cortical networks.

Authors:  Christian Meisel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-01       Impact factor: 11.205

2.  The interactions of nitric oxide and acetylcholine on penicillin-induced epilepsy in rats.

Authors:  Abdullah Hilmi Marangoz; Mehmet Yildirim; Mustafa Ayyildiz; Cafer Marangoz
Journal:  Neurochem Res       Date:  2012-03-08       Impact factor: 3.996

3.  Defining the structural parameters that confer anticonvulsant activity by the site-by-site modification of (R)-N'-benzyl 2-amino-3-methylbutanamide.

Authors:  Amber M King; Marc De Ryck; Rafal Kaminski; Anne Valade; James P Stables; Harold Kohn
Journal:  J Med Chem       Date:  2011-09-13       Impact factor: 7.446

Review 4.  The Role of Synapsins in Neurological Disorders.

Authors:  Fatima Javed Mirza; Saadia Zahid
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

5.  Suppression of seizure by cathodal transcranial direct current stimulation in an epileptic patient - a case report -.

Authors:  Soon-Won Yook; Sung-Hee Park; Jeong-Hwan Seo; Sun-Jun Kim; Myoung-Hwan Ko
Journal:  Ann Rehabil Med       Date:  2011-08-31

Review 6.  Alternating and postictal psychoses: review and a unifying hypothesis.

Authors:  Perminder S Sachdev
Journal:  Schizophr Bull       Date:  2007-03-03       Impact factor: 9.306

7.  Identification of the benzyloxyphenyl pharmacophore: a structural unit that promotes sodium channel slow inactivation.

Authors:  Amber M King; Xiao-Fang Yang; Yuying Wang; Erik T Dustrude; Cindy Barbosa; Michael R Due; Andrew D Piekarz; Sarah M Wilson; Fletcher A White; Christophe Salomé; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2012-09-19       Impact factor: 4.418

Review 8.  Computer modelling of epilepsy.

Authors:  William W Lytton
Journal:  Nat Rev Neurosci       Date:  2008-07-02       Impact factor: 34.870

Review 9.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 10.  Noninvasive brain stimulation protocols in the treatment of epilepsy: current state and perspectives.

Authors:  Michael A Nitsche; Walter Paulus
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.